Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study

Our previous study showed that administering oxaliplatin as first-line chemotherapy increased ERCC1 and DPD levels in liver colorectal cancers (CRCs) metastases. Second, whether the anti-VEGF monoclonal antibody bevacizumab alters tumoral VEGFA levels is unknown. We conducted this multicenter observ...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Hideo, Baba, Yoshifumi, Uemoto, Shinji, Yoshida, Kazuhiro, Saiura, Akio, Watanabe, Masayuki, Maehara, Yoshihiko, Oki, Eiji, Ikeda, Yasuharu, Matsuda, Hiroyuki, Yamamoto, Masakazu, Shimada, Mitsuo, Taketomi, Akinobu, Unno, Michiaki, Sugihara, Kenichi, Ogata, Yutaka, Eguchi, Susumu, Kitano, Seigo, Shirouzu, Kazuo, Saiki, Yasumitsu, Takamori, Hiroshi, Mori, Masaki, Hirata, Toshihiko, Wakabayashi, Go, Kokudo, Norihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741821/
https://www.ncbi.nlm.nih.gov/pubmed/26372896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741821/
https://www.ncbi.nlm.nih.gov/pubmed/26372896

Ejemplares similares